Contact & Support

Webinar: Current Applications and Advances in Fluorescence-guided Surgery

Wednesday, September 14, 2016

Participants will receive an overview on the concept of fluorescence-guided surgery (FGS) for the resection of brain and spinal cord tumors. Neurosurgeons will understand the current technologies available for FGS and the different tumor types that can undergo FGS. Safety, diagnostic accuracy, and Level 1 evidence in support of FGS will also be discussed.

Upon completion of this activity, participants should be able to:

  • Define the use of FGS for brain tumors with 5-aminolevulinic acid (5-ALA) and fluorescein;
  • Identify different brain and spinal cord tumor types that are amenable to FGS;
  • Distinguish the technical aspects of FGS, including the use of FGS for real-time intraoperative guidance, tumor margin visualization, and reported extents of tumor resection;
  • Explain patient safety with FGS;
  • Demonstrate the difference between current and future FGS technology; and
  • Summarize the current U.S. regulatory state for FGS.


Topics & Tags

Table of Content

Presented by:

Neurosurgery Research and Education Foundation (NREF) of the American Association of Neurological Surgeons (AANS)


Costas G. Hadjipanayis, MD, PhD

Neurosurgical Oncology director and professor and chair of the
Department of Neurosurgery at Mount Sinai Beth Israel

Brain Tumor Nanotechnology Laboratory director at the
Tisch Cancer Institute Icahn School of Medicine at Mount Sinai

This webinar contains content presented by the Neurosurgery Research and Education Foundation. Leica Microsystems’ sponsorship of this webinar does not necessarily imply Leica Microsystems’ recommendation or endorsement of the content of the webinar. Leica Microsystems does not make any representation or warranty about the content of the webinar and waives all responsibility for any content provided in the webinar.